Share Prices & Company Research

Stockbroking

Integrated Diagnostics Holdings

Current Price 4.90p Bid 4.90p Ask 4.95p Change 0.00%
Last Updated: 21/09/2019 10:24. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Integrated Diagnostic Holdings plc is the largest fully integrated private-sector medical diagnostics services provider in Egypt, Jordan and Sudan, comprehensively offering pathology and molecular diagnostics, genetics testing and basic radiology. IDH's core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan). IDH is listed on the London Stock Exchange (ticker: IDHC) and was founded in 2012 by the merger of Al Borg and Al Mokhtabar, the most established diagnostics services brands in Egypt. IDH's forward-looking strategy rests on leveraging its established business model to achieve four key strategic goals, namely: (1) continue to expand customer reach; (2) increase the number of tests per patient by expanding the Company's services portfolio; (3) expand into new geographic markets through selective, value-accretive acquisitions; and (4) introduce new medical services by leveraging the Group's network and reputable brand position.

Financial Highlights Year Ended 31/12/2018

Turnover
£1,921.45m
Operating Profit
£684.94m
Dividend Yield
0.00
Dividend Per Share
17.60
Dividend Cover
19.03
P/E Ratio
0.02

Key Personnel

Prof Hend El Sherbini
Chief Executive Officer
Lord Anthony Tudor St John of Bletso
Non-Executive Chairman
Richard Henry Phillips
Non-Executive Director
James Patrick Nolan
Non-Executive Director
Dan Olsson
Non-Executive Director
Hussein Choucri
Non-Executive Director
Ahmed Badreldin
Non-Executive Director

Stock Details

EPIC
IDHC
ISIN
JE00BV9H9G76
Shares in Issue
150,000,000
Market cap
£735.00m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
4.90p
Bid Price
4.90p
Ask Price
4.95p
Volume
109273
Change Today
0.00p
% Change Today
0.00%
Open
4.85p
Previous Close
4.90p
Intraday High
4.90p
Intraday Low
4.85p
52 Week High
5.25p
52 Week Low
3.30p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Integrated Diagnostics Holdings Intra-day Chart

Integrated Diagnostics Holdings News

News in this section is provided by AJ Bell

Integrated Diagnostics announces launch of new Egypt-based subsidiary 'Wayak' 10 Sep 2019 | 10:07

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
705.8
473.8
Intangible Assets & Goodwill
1,672.5
1,658.3
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
2,378.2
2,132.0
Inventory
91.1
69.9
Trade & Receivables
300.0
202.3
Cash & Receivables
412.6
685.2
Other Current Assets & Assets Held for Resale
251.9
22.4
Total Assets
3,433.8
3,111.8

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
669.3
485.4
Long Term Liabilities
363.8
312.3
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
1,033.2
797.7

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
2,400.6
2,314.1

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
1,072.5
1,072.5
Minority Interests
130.6
68.5
Retained Earnings
396.7
315.9
Share Premium Account
1,027.7
1,027.7
Other Equity
-226.9
-170.5
Total Equity
2,400.6
2,314.1

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
556.3
403.1
Cashflow Before Financing
90.7
369.2
Increase / Decrease in Cash
-268.0
-1.6

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
1,921.5
1,514.3
Cost of Sales
973.1
784.7
Gross Profit
948.4
729.6
Operating Profit
684.9
540.4
Pre-Tax Profit
717.4
558.4
Profit / Loss for the Year
496.9
383.7

Dividend History

Data has been provided by AJ Bell

Period
Ex-Dividend Date
Payment Date
H2 Dividend
16 May 2019
07 Jun 2019
H2 Dividend
17 May 2018
08 Jun 2018
H2 Dividend
11 May 2017
06 Jun 2017
H2 Dividend
07 Apr 2016
13 May 2016
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.